| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.3M | — | -12.9% |
| Cost of Revenue | $3.7M | — | -7.7% |
| Gross Profit | $2.6M | — | -19.6% |
| R&D Expense | $364K | — | +24.3% |
| SG&A Expense | $3.7M | — | +27.0% |
| Operating Income | -$2.1M | — | -259.4% |
| Pre-tax Income | -$2.1M | — | -219.6% |
| Net Income | -$2.1M | — | -221.3% |
| EPS (Basic) | -$0.07 | — | -133.3% |
| EPS (Diluted) | -$0.07 | — | -133.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.3M | -24.9% | +129.5% |
| Accounts Receivable | $5.1M | +18.1% | -13.5% |
| Inventory | $11.4M | +4.5% | +15.7% |
| Current Assets | $26.5M | -8.1% | +28.8% |
| Total Assets | $34.5M | -6.8% | +15.9% |
| Current Liabilities | $8.8M | -5.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.1M | — | -164.9% |
| Capital Expenditures | $46K | — | -65.1% |
| Investing Cash Flow | $50K | — | +130.5% |
| Financing Cash Flow | -$40K | — | — |
| Free Cash Flow | -$3.2M | — | -141.6% |
| -41.1% |
| Total Liabilities | $14.9M | -3.8% | -26.2% |
| Stockholders' Equity | $19.7M | -8.9% | +104.3% |